How many investments has Bailey Venture Partners made?

Bailey Venture Partners has 18 tracked investments, 3 of which have exited.

What stage does Bailey Venture Partners invest at?

Bailey Venture Partners invests at the Growth stage.

What sectors does Bailey Venture Partners focus on?

Bailey Venture Partners focuses on Biotech, Consumer, Digital Health, Healthtech, Medical Devices.

Bailey Venture Partners

Venture capital

Growth · 3 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Bailey Venture Partners

Your email: who you already know at Bailey Venture Partners, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bailey Venture Partners team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

Bail Capital focuses on backing category winners in stigmatized and heavily regulated markets, including cannabis, nicotine, and psychedelics. The firm seeks opportunities where others perceive excessive risk, aiming to transform these sectors into category-defining businesses. It frequently provides first institutional capital to founders and supports them over the long term, taking board and advisory roles across the portfolio. Areas of activity span therapeutics, medical devices, and functional consumer products, combining an institutional, disciplined approach with operator-investor experience to meet the expectations of top-tier limited partners.

Invests inBiotech Consumer Digital Health Healthtech Medical Devices

Source: firm website, verified Oct 2, 2026.

Leave your own feedback

Stage

Growth

Tracked investments

IPOs

Team · 3 people

from the firm's website

James Bailey· Managing General Partner

Founder of Bail Capital and Velos Partners, James is an experienced investor in emerging, stigmatized sectors including cannabis, nicotine, and psychedelics, having backed companies such as JUUL, PAX, Compass Pathways, MindMed, Mindbloom, and Kiva, often as their first institutional capital. He holds board and advisory roles across the Bail portfolio and leads the firm's category-first strategy.

Brent Cox· General Partner

Brent has deep experience in private equity, structured finance, and distressed investing, having spent nearly a decade at The Yucaipa Companies leading investments and restructurings across logistics, real estate, and consumer. He began his finance career at Jefferies. At Bail Capital he leads underwriting, capital strategy, and fund structuring.

Michael Cam-Phung· General Partner

Michael has two decades of investment and operating experience, most recently as Chief Strategy Officer at Seisa Medical where he led M&A and corporate development. He was previously a Principal at Highland Consumer Partners and worked in investment banking at William Blair and BMO Capital. At Bail Capital he supports founders in regulated markets and serves as a board observer for several portfolio companies.

What they invest in

from 14 of 18 portfolio companies

Biotech ×7Consumer ×6Digital Health ×6Mental Health ×6Wellness & Fitness ×5Direct to Consumer ×4Healthtech ×4Medical Devices ×4

HQs:United States×9United Kingdom×2Canada×1

Investments · 18 tracked

founders shown can be your intro path

AtaiBeckleyatai.lifeNASDAQ: ATAI

AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMental Health

Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)

Co-investorsAble Partners Alpha Wave Global AtaiBeckley Catalio Capital Management, LP FJ Labs Future Ventures +9 more

Compass Pathwayscompasspathways.com in 𝕏NASDAQ: CMPS

Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Kabir Nath(CEO)

Co-investorsAble Partners Aisling Capital Catalio Capital Management, LP Noetic OMX Ventures Vivo Capital+1 more

Helus Pharmahelus.com in 𝕏NASDAQ: HELP

Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder.

BiotechDigital HealthHealthtechMental HealthToronto, CA

Eric So(Co-Founder, Executive Chairman)in John Kanakis(Co-Founder)in Paul Glavine(Co-Founder and Chief Growth Officer)inGabriel Fahel(Executive Officer)Douglas Drysdale(Executive Officer)Jacqueline Poriadjian(Executive Officer)

Co-investorsInnovating Capital JLS Noetic O2h Ventures

Beckley Psytechbeckleypsytech.com

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao

Co-investorsFJ Labs Iter Investments Leafy Tunnel Noetic Palo Santo VC Redbus Ventures +3 more

Botanic Tonicsbotanictonics.com in

Botanic Tonics makes "feel free" consumer beverages and capsules formulated with botanicals such as kava root, leaf kratom, kola nut, rhodiola, and lion's mane, marketed for relaxation, mood, focus, and energy.

ConsumerDirect to ConsumerWellness & FitnessCalabasas, US

Jerry W. Ross(Manager)Cameron Korehbandi(Executive Officer)inSandro Starna(Executive Officer)in

Delixdelixtherapeutics.com in

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis Ventures Casa Verde Capital Dolby Family Ventures Noetic OMX Ventures Palo Santo VC +6 more

Drinkwilliesdrinkwillies.com

JUUL Labsjuul.com in

Washington, D.C., US

James Monsees(Executive Officer, Director)inAdam Bowen(Executive Officer, Director)inVittal Kadapakkam(Chief Financial Officer)inTyler Mace(Chief Legal Officer and Corporate Secretary)inK.C. Crosthwaite(Chief Executive Officer and Director)

BoardNicholas Pritzker(Director)

Co-investorsCianna Capital Evolution VC Partners Night Owl Ventures Jam Fund

Kiva Confectionskivaconfections.com in 𝕏

Kiva creates premium cannabis-infused edibles including bars, gummies, mints, and chews for legal adult consumers, emphasizing consistent dosing, natural ingredients, and sustainable packaging.

ConsumerDirect to ConsumerFoodTechWellness & Fitness

Scott PalmerinKristi Palmer

Co-investorsArtemis Growth Partners

LeafLinkleaflink.com

LeafLink is a wholesale platform connecting cannabis brands, distributors, and retailers, offering order management, payments via ACH or net terms, compliance automation, and logistics partner discovery.

B2B MarketplacesE-commerceFintechSaaSNew York, US

Ryan Smith(Co-founder)in Artie Minson(President and CEO)in

BoardZach Silverman(Co-founder)Andrew Greenfield(Director)in

Co-investorsCasa Verde Capital Fairhaven Capital Partners FJ Labs KEY Investment Partners Lerer Hippeau Muse Capital +7 more

Lifestyle Brand & E-commerce Platformmissgrass.com

Miss Grass is a cannabis brand that makes premium products including THC-infused gummies and flower, with a focus on effects and terpene profiles.

ConsumerDirect to ConsumerE-commerceFoodTechWellness & Fitness

Co-investorsAdvancit Capital Casa Verde Capital Five Four Ventures Helm Listen Ventures Merida Capital Holdings

Lucy Goods, Inclucy.co 𝕏

Lucy manufactures tobacco-free nicotine pouches in various flavors and strengths designed for consumer use.

BiotechConsumerE-commerceFoodTechLos Angeles, US

John Coogan(Founder)inSamy Hamdouche(Founder)in David Renteln(Founder)in

Co-investorsGreycroft Refactor Capital RRE Ventures Y Combinator BoxGroup Greycroft Partners +4 more

Mind Medicine (MindMed)mindmed.co in 𝕏

MindMed is a biotech company developing psychedelic-based therapeutics, including a proprietary orally disintegrating LSD tablet (DT120) and an R-enantiomer of MDMA (DT402), to treat brain health disorders such as generalized anxiety disorder, major depressive disorder, PTSD, and autism spectrum disorder.

BiotechDigital HealthMental HealthNew York, US

Stephen Hurst(Executive Officer, Director, Promoter)inScott Freeman(Executive Officer)JR Rahn(Director)STEPHEN HURST(Executive Officer, Director)inJAMON ALEXANDER RAHN(Executive Officer, Director)Carrie Liao(Executive Officer)in

Co-investorsBT Growth Capital Daft Capital K2 HealthVentures Noetic

Mindbloommindbloom.com in 𝕏

Mindbloom delivers guided ketamine therapy for depression and anxiety through a technology-enabled platform pairing clinicians with patients.

Digital HealthHealthtechMental HealthWellness & Fitness

Dylan Beynon(Founder)in

Co-investors8VC Four Acres Capital FundersClub Kleiner Perkins Long Journey Ventures FCVC +1 more

Nosaintnosaint.co

PAXpax.com in 𝕏

PAX makes cannabis vaporizer devices and related products for consumers, focused on flower and cannabis-based well-being.

ConsumerDirect to ConsumerHardwareWellness & Fitness

Co-investorsArtemis Growth Partners Evolution VC Partners Night Owl Ventures Sand Hill Angels

Players' Loungeplayerslounge.com 𝕏Seed

Players' Lounge is a wagering platform where gamers play money matches, tournaments, and challenges against others for cash prizes.

ConsumerCreator EconomyGamingMarketplacesSports TechNew York City, US

Zach Dixon(Co-founder)in Austin Woolridge(Co-founder)in Dan Delaney(Co-founder)in

Board Pierre Planche(Director)in

Co-investorsAlleyCorp Canaan Partners Comcast Ventures Courtside Ventures Dorm Room Evolution VC Partners +21 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Flowhub

Exits · 3

3 IPOs

AtaiBeckleyNASDAQ: ATAICompass PathwaysNASDAQ: CMPSHelus PharmaNASDAQ: HELP

Portfolio news

latest coverage across their companies

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) · finance.yahoo.com · Oct 29, 2025

Frequently asked questions

How many investments has Bailey Venture Partners made?: Bailey Venture Partners has 18 tracked investments, 3 of which have exited.
What stage does Bailey Venture Partners invest at?: Bailey Venture Partners invests at the Growth stage.
What sectors does Bailey Venture Partners focus on?: Bailey Venture Partners focuses on Biotech, Consumer, Digital Health, Healthtech, Medical Devices.